Literature DB >> 30094706

[Palliative therapy concepts for pancreatic carcinoma].

M Brunner1, R Grützmann1, G F Weber2.   

Abstract

The majority of patients with ductal pancreatic adenocarcinoma are already in a locally advanced or metastatic stage at the time of diagnosis and require palliative therapy. Interventional and operative measures are available for the restoration of biliary outflow in bile duct obstruction and the continuity of the upper intestinal lumen in duodenal or gastric outlet obstruction. In the presence of tumor-related pain, pain therapy according to the World Health Organization (WHO) scheme or a truncus coeliacus blockade, in cachexia a nutritional therapy and in thromboembolic events an anticoagulant therapy are used. An individualized palliative chemotherapy regimen should be selected for each patient, taking into account the patient's general condition and the side effects profile of the chemotherapeutic agents. Radiochemotherapy and local ablative therapies should currently only be used within the framework of studies. A palliative resection is not recommended according to current knowledge.

Entities:  

Keywords:  Antineoplastic treatment; Best supportive care; Bypass; Locally advanced pancreatic carcinoma; Metastatic pancreatic carcinoma

Mesh:

Year:  2018        PMID: 30094706     DOI: 10.1007/s00104-018-0696-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 2.  Supportive care in pancreatic ductal adenocarcinoma.

Authors:  B Laquente; A Calsina-Berna; A Carmona-Bayonas; P Jiménez-Fonseca; I Peiró; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

3.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

4.  [Prophylactic double bypass for unresectable pancreatic cancer : A gain for the patient?]

Authors:  M Schrempf; M Anthuber
Journal:  Chirurg       Date:  2016-12       Impact factor: 0.955

Review 5.  Megestrol acetate for treatment of anorexia-cachexia syndrome.

Authors:  Vicente Ruiz Garcia; Eduardo López-Briz; Rafael Carbonell Sanchis; Jose Luis Gonzalvez Perales; Sylvia Bort-Marti
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

Review 6.  Celiac plexus block for pancreatic cancer pain in adults.

Authors:  Paolo G Arcidiacono; Giliola Calori; Silvia Carrara; Ewan D McNicol; Pier A Testoni
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

7.  Palliative treatment of obstructive jaundice in patients with carcinoma of the pancreatic head or distal biliary tree. Endoscopic stent placement vs. hepaticojejunostomy.

Authors:  Marius Distler; Stephan Kersting; Felix Rückert; Frank Dobrowolski; Stephan Miehlke; Robert Grützmann; Hans-Detlev Saeger
Journal:  JOP       Date:  2010-11-09

Review 8.  Palliation of biliary and duodenal obstruction in patients with unresectable pancreatic cancer: endoscopy or surgery?

Authors:  F Maire; A Sauvanet
Journal:  J Visc Surg       Date:  2013-04-15       Impact factor: 2.043

Review 9.  Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness.

Authors:  A Dormann; S Meisner; N Verin; A Wenk Lang
Journal:  Endoscopy       Date:  2004-06       Impact factor: 10.093

10.  International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Authors:  Shuji Isaji; Shugo Mizuno; John A Windsor; Claudio Bassi; Carlos Fernández-Del Castillo; Thilo Hackert; Aoi Hayasaki; Matthew H G Katz; Sun-Whe Kim; Masashi Kishiwada; Hirohisa Kitagawa; Christoph W Michalski; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-11-22       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.